| Name | Autotaxin-IN-4 |
|---|
| Description | Autotaxin-IN-4 (compound 51), extracted from patent WO2018212534A1, is an Autotaxin inhibitor. Autotaxin-IN-4 has the potential to treat idiopathic pulmonary fibrosis[1]. |
|---|---|
| Related Catalog | |
| Target |
Autotaxin |
| References |
| Molecular Formula | C22H21N9O2 |
|---|---|
| Molecular Weight | 443.46 |